Celanese Showcases Medical Polymers at Pharmapack 2017

SHARE


DALLAS & PARIS–(BUSINESS WIRE)–
Celanese Corporation (NYSE: CE), a global technology and specialty
materials company, will showcase one of the broadest medical polymer
product portfolios in the industry at the 2017 Drug Delivery & Packaging
Pharmapack event at the Paris Expo Porte de Versailles in Paris, France.

At Pharmapack, Celanese will also introduce medical device researchers
and manufacturers to the Celanese MT® (Medical Technology) grade of
polymers used to design products capable of moving parts, precision
dosing and wear resistance. Celanese materials have supported diverse
customer applications and platforms including orthopedic implants,
insulin injection pens, asthma inhalers, syringes and surgical staple
cartridges.

“Celanese has been supporting our customers’ growth in medical devices
and platforms for decades. We continue to provide a broad materials
portfolio covering a wide range of chemical resistance, mechanical
performance and usage temperatures,” said Isaac Khalil, vice president
of Celanese’s Global Medical business. “Celanese also has the ability to
customize materials to meet our customers’ specific CTQs, and our
technical teams can provide computer-aided engineering services to
support part design and processing across our customers’ manufacturing
ecosystem. We look forward to showcasing Celanese’s MT® portfolio,
technical engagement model and services at Pharmapack 2017.”

Celanese will also offer a Learning Lab Presentation at Pharmapack to
discuss its unique medical device materials:

Topic:

   

Vectra® LCP – A Unique Material for Medical Devices

Date/Time:

Thursday, February 2nd at 10:10-10:40
a.m. local time

Presenter:

Wendy Johnson, Customer & Application Marketing Manager, Medical

Celanese medical polymer experts will be meeting with Pharmapack
attendees at Booth C80 in Hall 4 at the Paris expo Porte de Versailles
February 1-2. For more information about Celanese’s medical and
pharmaceutical materials solutions, visit http://healthcare.celanese.com/.

About Celanese

Celanese Corporation is a global technology leader in the production
of differentiated chemistry solutions and specialty materials used in
most major industries and consumer applications. Our two complementary
business cores, Acetyl Chain and Materials Solutions, use the full
breadth of Celanese’s global chemistry, technology and business
expertise to create value for our customers and the corporation. As we
partner with our customers to solve their most critical business needs,
we strive to make a positive impact on our communities and the world
through The Celanese Foundation. Based in Dallas, Celanese employs
approximately 7,000 employees worldwide and had 2015 net sales of $5.7
billion. For more information about Celanese and our product offerings,
visit
www.celanese.com
or our blog at
www.celaneseblog.com.

All registered trademarks are owned by Celanese International
Corporation or its affiliates.

Forward-Looking Statements

This release may contain “forward-looking statements,” which include
information concerning the company’s plans, objectives, goals,
strategies, future revenues or performance, capital expenditures,
financing needs and other information that is not historical
information. When used in this release, the words “outlook,” “forecast,”
“estimates,” “expects,” “anticipates,” “projects,” “plans,” “intends,”
“believes,” and variations of such words or similar expressions are
intended to identify forward-looking statements. All forward-looking
statements are based upon current expectations and beliefs and various
assumptions. There can be no assurance that the company or its customers
will realize these benefits or that these expectations will prove
correct. There are a number of risks and uncertainties that could cause
actual results to differ materially from the forward-looking statements
contained in this release. Numerous factors, many of which are beyond
the company’s control, could cause actual results to differ materially
from those expressed as forward-looking statements. Other risk factors
include those that are discussed in the company’s filings with the
Securities and Exchange Commission. Any forward-looking statement speaks
only as of the date on which it is made, and the company undertakes no
obligation to update any forward-looking statements to reflect events or
circumstances after the date on which it is made or to reflect the
occurrence of anticipated or unanticipated events or circumstances.

Celanese Corporation
Investor Relations
Surabhi
Varshney, +1-972-443-3078
surabhi.varshney@celanese.com
or
Media
Relations – Global

W. Travis Jacobsen, +1-972-443-3750
william.jacobsen@celanese.com
or
Media
Relations Asia (Shanghai)

Helen Zhang, +86 21 3861 9279
lan.zhang@celanese.com
or
Media
Relations Europe (Germany)

Jens Kurth, +49(0)69 45009 1574
j.kurth@celanese.com

Source: Celanese Corporation


SHARE
Previous articleConformal Coating
Next articleFloor Coating